MERRIMACK PHARMACEUTICALS INC Noncontrolling Interest, Decrease from Deconsolidation
MERRIMACK PHARMACEUTICALS INC reported Noncontrolling Interest, Decrease from Deconsolidation of $1.85 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Shareholders' Equity
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2018-03-12
- MERRIMACK PHARMACEUTICALS INC noncontrolling interest, decrease from deconsolidation for the quarter ending 2017-12-31 was $3.70M.
- MERRIMACK PHARMACEUTICALS INC noncontrolling interest, decrease from deconsolidation for fiscal 2017 was $1.85M.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month | Noncontrolling Interest, Decrease from Deconsolidation 9 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month |
|---|---|---|---|
| 2017-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.85M 10-K · filed 2018-03-12 | |
| 2017-09-30 | -$1.85M 10-Q · filed 2017-11-08 |